Glucose Health, Inc. (GLUC) stock
Close on Oct 19, 2026Market cap $1.82MP/E –Yield –
Glucose Health, Inc. saw revenue fall 70.6% to $88.13K over the twelve months to Sep 30, 2017. At the latest close the market valued the company at $1.82M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2017
Valuation
- Market cap
- $1.82M
- P/E ratio
- –
- Price to sales
- 20.71
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $88.13K
- Net income
- -$85.06K
- EPS, diluted
- -$0.04
- Book value per share
- -$0.10
- Diluted shares
- 4M
Trading
- Previous close
- $0.34
- Open
- $0.39
- Day's range
- $0.39 – $0.44
- Volume
- 5,000
- Average volume (20 days)
- 15,177
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | GLUC | S&P 500 | Difference | GLUC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +26.4% | +0.6% | +25.8 pts | ||
| 3 months | +37.5% | +3.4% | +34.1 pts | ||
| Year to date | +106.5% | +13.3% | +93.2 pts | ||
| 1 year | +1153.3% | +16.6% | +1136.7 pts | ||
| 3 years | +100.0% | +86.4% | +13.6 pts | +26.0% | +23.1% |
| 5 years | -80.2% | +81.9% | −162.0 pts | -27.7% | +12.7% |
| 10 years | +645.6% | +318.9% | +326.7 pts | +22.3% | +15.4% |
Eight years at a glance
Fiscal years 2009 to 2016 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
About Glucose Health
Medicinal Chemicals & Botanical Products
Glucose Health, Inc. manufactures dietary supplements designed to support healthy blood sugar, triglyceride, and cholesterol levels, as well as promote digestive health. Its primary offering is Glucose Health®, a dietary supplement formulated with soluble fiber and plant-based extracts. The company targets consumer markets concerned with pre-diabetes and Type-2 diabetes. It distributes its products primarily through national and regional pharmacy retailers, while also offering direct sales to consumers via dedicated websites and online marketplaces.
Company profile, executives and historyGlucose Health stock: common questions
What is Glucose Health's stock price?
GLUC closed at $0.44 on Oct 19, 2026, up 28.76% on the day.
What is Glucose Health's market cap?
Glucose Health was worth $1.82M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is GLUC's P/E ratio?
Glucose Health lost money over the twelve months to Sep 30, 2017 (diluted EPS -$0.04), so it has no meaningful P/E ratio.
How much revenue does Glucose Health make?
Glucose Health reported revenue of $88.13K for the twelve months to Sep 30, 2017, down 70.6% from a year earlier.
Does Glucose Health pay a dividend?
No. Glucose Health has not paid a cash dividend over the last twelve months.
How has GLUC stock performed over the past year?
Including dividends, GLUC returned +1153.3% over the past year, against +16.6% for the S&P 500.
Who are Glucose Health's competitors?
Companies most similar to Glucose Health by business, industry and size include HYEX, FTLF, MTEX, NTRR, NAII.
See a number that looks wrong?